$TECH 3 SEC Filings

Filed On	Filing
04 Mar 2026	Form 3: Crouse Steven C., President - Diag & Spatial Bi Holds 5,894 shares of Common Stock
07 Feb 2025	Form 3: Herr Amy E., Director Holds 1,860 shares of Common Stock
03 May 2024	Form 3: Klimovsky Judith V, Director No securities owned
05 Feb 2024	Form 3: McManus Matthew, President - DGS No securities owned
04 Apr 2023	Form 3: Bohnen Shane, SVP - General Counsel Holds 135 shares of Common Stock
03 Feb 2022	Form 3: Geist William, President, Protein Sciences No securities owned
05 Aug 2020	Form 3: Bushman Julie L, Director No securities owned
02 Jul 2019	Form 3: Vessey Rupert, Director No securities owned
03 May 2018	Form 3: Kelderman Kim, President, Diagnostics & Genom No securities owned
31 Oct 2017	Form 3: Keegan Joseph D, Director No securities owned
30 Oct 2017	Form 3: Seth Alpna, Director No securities owned
06 Jan 2016	Form 3: Gould Kevin S, SVP Clinical Controls Holds 2,500 shares of Common Stock
03 Dec 2014	Form 3: Gavin Robert M., Sen. VP Protein Platforms Holds 5,000 shares of Common Stock
06 Aug 2014	Form 3: Furlow Brenda S., SVP - General Counsel No securities owned
07 Jul 2014	Form 3: Eansor N David, SVP - Novus Biologicals No securities owned
15 May 2014	Form 3: Wiens Harold J, Director No securities owned
01 Apr 2014	Form 3: Hippel James, Chief Financial Officer No securities owned
05 Aug 2013	Form 3: Reagan Kevin J, Senior VP Biotech
05 Aug 2013	Form 3: Bazan J. Fernando, Chief Technical Officer No securities owned
02 Apr 2013	Form 3: Kummeth Charles R., Director No securities owned

Comments